A l’occasion du déplacement du Premier ministre Michel Barnier et du ministre de l’Economie Antoine Armand dans la région #Auvergne-Rhône-Alpes, EUROAPI a eu l’opportunité de participer à la séquence #France2030. « Ce plan d’investissement est un soutien indispensable pour transformer durablement notre outil de production localisé en France », a expliqué Sylvia Cabrillac-Rives, aux côtés de Bruno Bonnell. « En nous permettant d’innover pour développer des technologies de pointe et des procédés industriels plus respectueux de l’environnement, France 2030 contribue à rendre compétitives des molécules essentielles, et à sécuriser l’approvisionnement en produits de santé au bénéfice des patients français et européens. » #souveraineté #API #RSE #chimie
EUROAPI
Fabrication de produits pharmaceutiques
Paris, Île-de-France 18 999 abonnés
Active Solutions for Health
À propos
EUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world. We are a leading player in active pharmaceutical ingredients with approximately 200 products in our portfolio, offering a large span of technologies, while developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO) activities. Taking action for health by enabling access to essential therapies inspires our 3,450 people every day. With strong research and development capabilities and six manufacturing sites all located in Europe (Saint-Aubin-lès-Elbeuf and Vertolaye in France, Brindisi in Italy, Frankfurt in Germany, Budapest in Hungary and Haverhill in the UK), EUROAPI ensures API manufacturing of the highest quality to supply customers in more than 80 countries. EUROAPI is listed on Euronext Paris. OUR VISION Reinventing active ingredient solutions to sustainably meet clients’ and patients’ needs around the world in a sustainable way. OUR MISSION We work passionately every day to develop, manufacture and supply active-ingredient solutions for our healthcare partners around the world. We combine our scientific excellence with industrial expertise and a wide range of technologies to deliver solutions that meet the highest quality, social and environmental requirements - all while ensuring stakeholder satisfaction. OUR FUNDAMENTALS We are driven by the success of our clients and their satisfaction * Reliability * EUROAPI is the leading small molecules API player with an unique European industrial platform and proven track record for reliability. * Quality * EUROAPI provides you with active ingredients that meet the highest pharmaceutical standards. * Premium Client Service * EUROAPI manufactures your success through tailored solutions and a long-term partnership approach that provides peace of mind.
- Site web
-
https://www.euroapi.com/
Lien externe pour EUROAPI
- Secteur
- Fabrication de produits pharmaceutiques
- Taille de l’entreprise
- 1 001-5 000 employés
- Siège social
- Paris, Île-de-France
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2021
- Domaines
- CDMO, API Solutions, R&D, API Development, API Production, API Distribution, Vitamin B12, Prostaglandines, Alkaloids, Anti-infectives, Corticoteroids and Hormones, Spray-drying, Micronization, Oligonucleotides, Peptides, Particle engineering, Microbial fermentation, Small molecules, Drug delivery solutions, Custom development et API for clinical studies
Lieux
Employés chez EUROAPI
Nouvelles
-
📰 EUROAPI R&D is in Sustainable #Chemistry & Engineering We are thrilled to announce that our research article on “advancing sustainability in #peptide synthesis” has been published in Sustainable Chemistry & Engineering, a journal of the American Chemical Society. The study, led by Eugénie Fournier, Arjun Vijeta, Oleg Babii, Mohamad Jamal Wawi, Bernd Henkel, and Hélène Adihou, introduces a groundbreaking method that combines real-time monitoring using Raman spectroscopy, the use of a rotating bed reactor, and the substitution of traditional solvents with greener alternatives. This pioneering work not only advances the field of peptide synthesis but also sets a new standard for sustainability in the pharmaceutical industry. Read the news👉https://lnkd.in/eHW6DVnx
-
-
Les métiers de la #chimie vous intéressent ? Ecoutez #audreybernardon, ingénieure sécurité des procédés chez #euroapi à Vertolaye (Puy-de-Dôme), parler avec passion de son quotidien professionnel. Et pour en savoir plus sur nos sites, c’est 👉 https://lnkd.in/eXbtE4cj #HSE
Vidéos métiers 🎬 TVLF Travailler et Vivre en Livradois Forez Nous poursuivons notre nouvelle série de portraits de salarié.es par celui d'Audrey, Ingénieure sécurité des procédés à EUROAPI Vertolaye. Un grand merci à elle et Cedric Van Der Meiren pour leur confiance 😉 https://lnkd.in/eX9wrmKE 🙏 France Travail Ambert et CCI Puy-de-Dôme Clermont Auvergne Métropole pour leur soutien financier dans la réalisation de ces belles vidéos ! #métier #industrie #chimie #sécurité #livradoisforez
-
EUROAPI announces its collaboration with Aizon for a new AI-powered eBR (electronic Batch Record) light solution to enhance its manufacturing productivity. The software product will digitize operations towards more data-driven manufacturing - focusing on the essential user needs while avoiding the heavy lift currently associated with going paperless in manufacturing. “Existing eBR options do not match the realities of how APIs are manufactured today. Our collaboration with Aizon to design a lightweight, purpose-oriented and essential eBR, represents a pivotal step in our digital transformation journey, with our vision to streamline and optimize our processes,” said David Seignolle, Chief Operating Officer of Euroapi. Learn more 👉https://lnkd.in/d_CtzQZF #apisolutions #CDMO #CPHI
-
📰 "Shift from Manufacturer to Technology Leader", by Ludwig de Mot In anticipation of CPHI, the 2024 third edition of CHEManager International includes a feature on #CDMOs. In this issue that has just been published, Ludwig de Mot, CEO of EUROAPI, shares his views on how companies are dealing with the changing CDMO economic environment and the resulting opportunities and challenges. Extract: 💬 “At EUROAPI, we partner a wide range of organizations, from biotech to big pharma companies, to address their needs for innovative molecules such as peptides and oligonucleotides […] With the boom in precision medicine, we act as an enabler for targeted therapies notably in the domains of rare diseases, the central nervous system, oncology, and immunology.” Full article on page 16 ⤵️ https://lnkd.in/e5PeVjZb Enjoy your reading!
-
📅#CPHIMilan is coming soon! EUROAPI teams look forward to meeting with you at CPHI in Milan. 🤝 Visit us at stand 5A113, to discover our API portfolio and learn about our best-in-class #CDMO capabilities. 📧 Feel free to contact us to schedule a meeting: 👉 [email protected] 👉 https://lnkd.in/ebtyCefs See you in Italy! #apisolutions #CPHI2024
-
-
“Securing sustainable domestic production of critical APIs is the cornerstone of European citizens protection system shared across all member states and recent shortage events reinforce this urgent need,” said Vincent Touraille. #CDMO #apisolutions
𝐔𝐧 𝐂𝐫𝐢𝐭𝐢𝐜𝐚𝐥 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 𝐀𝐜𝐭 𝐞𝐬𝐭 𝐧𝐞́𝐜𝐞𝐬𝐬𝐚𝐢𝐫𝐞 𝐩𝐨𝐮𝐫 𝐠𝐚𝐫𝐚𝐧𝐭𝐢𝐫 𝐧𝐨𝐬 𝐦𝐞́𝐝𝐢𝐜𝐚𝐦𝐞𝐧𝐭𝐬 𝐞𝐬𝐬𝐞𝐧𝐭𝐢𝐞𝐥𝐬 tel fut le message porté par le SICOS (chimie fine & biotech) lors de la réunion de la 𝐶𝑟𝑖𝑡𝑖𝑐𝑎𝑙 𝑀𝑒𝑑𝑖𝑐𝑖𝑛𝑒𝑠 𝐴𝑙𝑙𝑖𝑎𝑛𝑐𝑒. La filière industrielle du médicament s’érode d’année en année, nous appelons à un sursaut de l’Europe pour soutenir, valoriser et protéger/développer une production locale et durable de médicaments, notamment essentiels. 📌 Communiqué de presse : https://bit.ly/4d2apns Pharmaceutiques - actulabo - Contexte - AFP - Les Echos - Le Figaro - Infopro Digital
-
🔑 Open possibilities with EUROAPI at #ChemOutsourcing 🤝 Come and visit us at ChemOutsourcing in Parsippany, NJ (September 3-6). Our CDMO US team is looking forward to meeting you at our booth #74 to discuss your projects. See you soon! #cdmo #apisolutions
-
-
Last week, EUROAPI participated in the International Oligonucleotides and Peptides Conference in Milan and our expert, Hélène Adihou, gave a presentation about ‘Advances in peptide synthesis with green chemistry and cutting-edge technologies’. 🙏 We thank all the attendees for their interest and attention! If you missed this presentation, our experts are still available to provide you with these details and answer your questions. 📧 Feel free to contact us to get more information: 👉 [email protected] 👉 https://lnkd.in/ebtyCefs See you soon! #IOPC #bianoGMP #cdmo #innovation #oligonucleotides #peptides #tides
-
-
𝗘𝘁 𝘀𝗶 𝗹𝗲𝘀 𝗺𝗮𝗿𝗰𝗵𝗲́𝘀 𝗽𝘂𝗯𝗹𝗶𝗰𝘀 𝗳𝗮𝘃𝗼𝗿𝗶𝘀𝗮𝗶𝗲𝗻𝘁 𝗹’𝗮𝗰𝗵𝗮𝘁 𝗱𝗲 𝗽𝗿𝗼𝗱𝘂𝗶𝘁𝘀 𝗱𝘂𝗿𝗮𝗯𝗹𝗲𝘀 ? C’est l’une des 10 recommandations que nous portons 👇 Nous avons fait le choix stratégique du « Fabriqué en France ». Pour autant, nos TPE-PME et ETI de la filière du médicament en France sont en grande difficulté. Dans ce carrousel, découvrez nos 10 recommandations pour : ➡️ Continuer à verdir notre industrie ➡️ Avoir un prix juste qui tienne compte de notre « Fabriqué en France » ➡️ Maintenir la production de médicaments en France L’enjeu ? ✅ Garantir l’accessibilité des médicaments aux patients en France ✅ S’inscrire dans une perspective durable au service de la souveraineté sanitaire et industrielle de la France 👉 Lisez notre tribune pour sauver notre filière industrielle du médicament en France (page 6 de Pharmaceutiques - Juin-Juillet 2024) 🔗 https://lnkd.in/exjyjb5D 👉 Prêts à soutenir notre mouvement ? Likez, commentez et partagez ce post @SICOS @CDMO France @AMLIS @METI @Stéphane Lepeu @Karine Pinon @Laure Lechertier #tribune #santé #madeinfrance #industrie ** Entreprises du SICOS, de CDMO France, de l’AMLIS et du METI, nous produisons en France 35% des médicaments essentiels du quotidien et employons 50 000 collaborateurs sur nos 130 sites industriels.